Sericin improves cognitive outcomes in a mouse model of cerebral ischemia: The role of Blood-Brain Barrier disruption and edema
Advanced Pharmaceutical Bulletin · 29.06.2026
DOI: 10.34172/apb.46668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 29.06.2026. Verfasst von Leila Hosseini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
Oxidative stress, edema, and blood-brain barrier (BBB) dysfunction are involved in the pathophysiology of stroke and may offer opportunities for managing its related insults. Sericin (Ser) has neuroprotective and pro-cognitive effects. This study aimed to determine whether Ser could reduce cerebral edema and its associated molecular and cognitive abnormalities in a mouse model of cortical ischemia. Methods:The mice were allocated into five cohorts: Sham, normal saline (NS), Ser200, Ser300, and Ser400. Each group received its treatment for 14 days before being subjected to cerebral ischemia or a sham surgery procedure. Spatial memory was assessed using the Lashley III maze. Brain edema, BBB permeability, malondialdehyde (MDA) level, and changes in anti-oxidant markers (total antioxidant capacity (TAC) levels, as well as superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities) were evaluated in the brain samples. Additionally, the expression of BBB structural integrity proteins, including occludin and zonula occludens-1 (ZO-1), and matrix metalloproteinase-9 (MMP-9), were analyzed.
Results
Ser300 and Ser400 improved spatial memory (at least p< 0.05). Also, Ser400 reduced brain water content (p< 0.05), Ser300 and 400 decresed BBB leakage (at least p< 0.05), and normalized anti-oxidant markers (at least p< 0.05). As well, Ser400 diminished MDA content (p< 0.05). All doses decreased MMP-9 levels (at least p< 0.01). Ser400 upregulated the expression of occludin (p< 0.01), and Ser300 and 400 increased ZO-1 proteins (at least p< 0.05).
Conclusion
Ser improved cognitive dysfunction associated with BBB damage and edema induced by cerebral ischemia in a mouse model.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.
- Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090, Vienna, Austria.
- Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Leila Hosseini, Javad Mahmoudi
Zitieren
APA
Hosseini, L., Vatandoust, S. M., Farazi, N., Pasokh, A., Sadigh-Eteghad, S., Farzipour, M., Farajdokht, F., Mohajjel Nayebi, A., Hassanzadeh, A., & Mahmoudi, J. (2026). Sericin improves cognitive outcomes in a mouse model of cerebral ischemia: The role of Blood-Brain Barrier disruption and edema. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.46668
Vancouver
Hosseini L, Vatandoust SM, Farazi N, Pasokh A, Sadigh-Eteghad S, Farzipour M, et al. Sericin improves cognitive outcomes in a mouse model of cerebral ischemia: The role of Blood-Brain Barrier disruption and edema. Advanced Pharmaceutical Bulletin. 2026. doi:10.34172/apb.46668
BibTeX
@article{Hosseini2026,
author = {Hosseini, Leila and Vatandoust, Seyed Mehdi and Farazi, Narmin and Pasokh, Amir and Sadigh-Eteghad, Saeed and Farzipour, Mohammad and Farajdokht, Fereshteh and Mohajjel Nayebi, Alireza and Hassanzadeh, Ali and Mahmoudi, Javad},
title = {Sericin improves cognitive outcomes in a mouse model of cerebral ischemia: The role of Blood-Brain Barrier disruption and edema},
journal = {Advanced Pharmaceutical Bulletin},
year = {2026},
doi = {10.34172/apb.46668}
}
EUVIMED